Clinical Trials

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Resnick, S. M
Right arrow Articles by Shumakerb, S. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Resnick, S. M
Right arrow Articles by Shumakerb, S. A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Trials, Vol. 1, No. 5, 440-450 (2004)
DOI: 10.1191/1740774504cn040oa
© 2004 The Society for Clinical Trials

The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline

Susan M Resnick

Laboratory of Personality and Cognition, National Institute on Aging, Baltimore, Maryland, USA; National Institute on Aging, 5600 Nathan Shock Drive, Box 03, Baltimore, Maryland 21224-6825, USA susan.resnick{at}nih.gov

Laura H Cokerb

Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina

Pauline M Makia

Laboratory of Personality and Cognition, National Institute on Aging, Baltimore, Maryland, USA; Department of Psychiatry, University of Illinois, Chicago

Stephen R Rapp

Department of Public Health Sciences, Department of Psychiatry and Behavioral Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina

Mark A Espeland

Sally A Shumakerb

Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina

The Women's Health Initiative Study of Cognitive Aging (WHISCA) was a two armed, randomized, placebo controlled, clinical trial designed to assess the efficacy of postmenopausal hormone therapy on age related changes in specific cognitive functions. WHISCA was an ancillary study to the Women's Health Initiative (WHI) and the WHI Memory Study (WHIMS) and enrolled 2302 women aged 66 to 84 years (mean 73.9; standard deviation 3.8) who did not meet criteria for dementia. Women were randomly assigned by the WHI to hormone treatment (unopposed conjugated estrogens (CEE) 0.625 mg/day if they were without a uterus; CEE combined with medroxyprogesterone acetate (MPA) 2.5 mg/day otherwise) or placebo for an average of three years before the first WHISCA assessment. WHISCA investigated the effects of hormone therapy on rates of change over time in memory, other aspects of cognition (language, attention, spatial ability), motor function, and mood. In this paper, we present the study rationale and design, including specific cognitive measures, and the challenges of incorporating WHISCA into an ongoing randomized trial. WHISCA provided a unique opportunity to investigate the potential of hormone therapy to modify age related changes in specific cognitive functions. WHISCA also demonstrated the feasibility of adding a detailed cognitive assessment into an ongoing clinical trial to address an important issue in women's health, despite the challenges of maintaining the integrity of the parent studies, ensuring high retention, and achieving high quality assurance across sites.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
L. K. Marriott, K. R. McGann-Gramling, B. Hauss-Wegrzyniak, L. C. Sheldahl, R. A. Shapiro, D. M. Dorsa, and G. L. Wenk
Brain Infusion of Lipopolysaccharide Increases Uterine Growth as a Function of Estrogen Replacement Regimen: Suppression of Uterine Estrogen Receptor-{alpha} by Constant, But Not Pulsed, Estrogen Replacement
Endocrinology, January 1, 2007; 148(1): 232 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. M. Resnick, P. M. Maki, S. R. Rapp, M. A. Espeland, R. Brunner, L. H. Coker, I. A. Granek, P. Hogan, J. K. Ockene, S. A. Shumaker, et al.
Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1802 - 1810.
[Abstract] [Full Text] [PDF]